Skin Cancer Screening Education Study

NCT02352428 | Unknown

• 1 other identifier: LEO-SCSES_1013
• Study Type: interventional
• Target: 113
• Locations: 1 country
• Sites: 1

Brief Summary

The overall aim of this population-based screening study is to assess whether the skin cancer screening training of family physicians and dermatologists leads to improved screening outcomes. The training course aims to increase the accuracy of detecting early stages of skin cancer. Screening outcomes of an intervention region (Calgary, Canada) in which physicians receive training will be compared with screening outcomes of a control region (Edmonton, Canada) where no physician training is administered. The investigators will determine whether:

• clinical screening outcomes are more favorable in the group of trained physicians compared to non trained physicians
• there is an increase of knowledge about skin cancer screening among trained physicians, compared to non trained physicians
• skin cancer screenings are associated with psycho-social harms
• population-based screening has an effect on the overall incidence and stage-specific-incidence of skin cancer in Alberta The investigators are aiming to recruit 100 physicians per region (total of 200 physicians) who will screen 40,000 to 80,000 individuals over a period of 20 months.

Conditions

Skin Tumors; Melanoma; Basal Cell Carcinoma; Squamous Cell Carcinoma

Keywords

Skin Cancer; Secondary Prevention; Population Screening

Outcome Measures

Primary Outcomes (4)

• Change in the diagnostic accuracy including knowledge on skin cancer screening

  Educational outcomes of physicians will be measured pre- and post-training using knowledge tests in the intervention and control region

  month 1 pre-training (intervention and control region), month 1 post-training (intervention region only), and month 12 (both regions)

• Number needed to screen (NNS) to identify 1 skin tumor and number needed to excise (NNE) to identify 1 skin tumor

  Case report forms will be analyzed to determine clinical screening outcomes such as the NNS, NNE and tumor thickness.

  20 months

• Patient-rated well-being

  A patient questionnaire will be used to assess psycho-social harms of skin cancer screenings.

  20 months

• Trends of overall skin cancer incidence and stage-specific-incidence

  Up to 6 years (2012-2018)

Study Arms (2)

Skin Cancer Screening Training

EXPERIMENTAL

Recruited family physicians and dermatologists in Calgary, Canada, take part in a 5.5-hour face-to-face skin cancer screening training program. Screening for skin cancer will be conducted by trained physicians according to instructions they received in the training program.

Other: Skin Cancer Screening Training

No Skin Cancer Screening Training

NO INTERVENTION

Recruited family physicians and dermatologists in Edmonton, Canada, WILL BE TRAINED AFTER THE SCREENING PHASE, i.e. during the screening phase non-trained physicians will carry out skin cancer screenings according to standard medical practice.

Interventions

Skin Cancer Screening Training OTHER

Topics of the 5.5-hour in-class course include: the screening test, types of skin cancer (signs and symptoms), case history taking, epidemiology of skin cancer, etiology, risk factors and risk groups, communicative aspects of primary and secondary preventive measures, and benefits and harms of cancer screenings.

Skin Cancer Screening Training

Eligibility Criteria

• Age: 20 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Screenees
• Male and female residents of Alberta mainly living and receiving care in Edmonton or in Calgary
• Age 20+
• English-speaking
• Individuals who consent to participate
• Physicians
• Registered dermatologists and family physicians administering care either in Edmonton or in Calgary
• English-speaking
• Physicians who consent to participate

You may not qualify if:

• Physicians who have undergone special training in skin cancer screening within the last 2 years

Sponsors & Collaborators

• Association of Dermatological Prevention, Germany: lead
• University of Calgary: collaborator
• University of Alberta: collaborator

Study Sites (1)

University of Calgary, University of Alberta

Calgary, Edmonton, Alberta, Canada

Location

Related Links

• Study website

MeSH Terms

Conditions

Skin Neoplasms; Melanoma; Carcinoma, Basal Cell; Carcinoma, Squamous Cell

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Skin Diseases; Skin and Connective Tissue Diseases; Neuroendocrine Tumors; Neuroectodermal Tumors; Neoplasms, Germ Cell and Embryonal; Neoplasms by Histologic Type; Neoplasms, Nerve Tissue; Nevi and Melanomas; Carcinoma; Neoplasms, Glandular and Epithelial; Neoplasms, Basal Cell; Neoplasms, Squamous Cell

Study Officials

• Lynne H Robertson, MD, FRCPC

  University of Calgary

  PRINCIPAL INVESTIGATOR

• Gordon E Searles, MD, FRCPC

  University of Alberta

  PRINCIPAL INVESTIGATOR

• Eckhard W Breitbart, MD, PhD

  Association of Dermatological Prevention, Germany

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: SCREENING
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 13, 2015
• First Posted: February 2, 2015
• Study Start: February 1, 2015
• Primary Completion: December 1, 2018
• Study Completion: September 1, 2019
• Last Updated: May 6, 2019

Record last verified: 2019-05

Locations

CA (1)